81 related articles for article (PubMed ID: 17617377)
1. DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation.
Collado D; Yoshihara T; Hamaguchi M
Biochem Biophys Res Commun; 2007 Aug; 360(3):600-3. PubMed ID: 17617377
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function.
Yoshihara T; Collado D; Hamaguchi M
Biochem Biophys Res Commun; 2007 Jul; 358(4):1076-9. PubMed ID: 17517369
[TBL] [Abstract][Full Text] [Related]
3. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
[TBL] [Abstract][Full Text] [Related]
4. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.
Zhang Q; Tian L; Mansouri A; Korapati AL; Johnson TJ; Claret FX
FEBS Lett; 2005 Jul; 579(18):3932-40. PubMed ID: 15996662
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the DBC2 gene and its clinicopathological significance in breast cancer: correlation with aberrant DNA methylation.
Han L; Hou L; Song J; Lin D; Wu L; Ge Y; Ma Z
Biotechnol Lett; 2013 Aug; 35(8):1175-81. PubMed ID: 23546941
[TBL] [Abstract][Full Text] [Related]
7. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways.
Siripurapu V; Meth J; Kobayashi N; Hamaguchi M
J Mol Biol; 2005 Feb; 346(1):83-9. PubMed ID: 15663929
[TBL] [Abstract][Full Text] [Related]
8. Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex.
Manjarrez JR; Sun L; Prince T; Matts RL
PLoS One; 2014; 9(3):e90054. PubMed ID: 24608665
[TBL] [Abstract][Full Text] [Related]
9. RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor.
Freeman SN; Cress WD
Cancer Biol Ther; 2010 Dec; 10(11):1123-5. PubMed ID: 20980811
[No Abstract] [Full Text] [Related]
10. DBC2 is essential for transporting vesicular stomatitis virus glycoprotein.
Chang FK; Sato N; Kobayashi-Simorowski N; Yoshihara T; Meth JL; Hamaguchi M
J Mol Biol; 2006 Dec; 364(3):302-8. PubMed ID: 17023000
[TBL] [Abstract][Full Text] [Related]
11. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
[TBL] [Abstract][Full Text] [Related]
12. DBC2 gene is silenced by promoter methylation in bladder cancer.
Shi Y; Chen JY; Yang J; Li B; Chen ZH; Xiao CG
Urol Oncol; 2008; 26(5):465-9. PubMed ID: 18640857
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
14. DBC2, a candidate for a tumor suppressor gene involved in breast cancer.
Hamaguchi M; Meth JL; von Klitzing C; Wei W; Esposito D; Rodgers L; Walsh T; Welcsh P; King MC; Wigler MH
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13647-52. PubMed ID: 12370419
[TBL] [Abstract][Full Text] [Related]
15. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
16. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
17. Activation of hypoxia-induced transcription in normoxia.
Hägg M; Wennström S
Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
[TBL] [Abstract][Full Text] [Related]
18. Mouse homologue of yeast Prp19 interacts with mouse SUG1, the regulatory subunit of 26S proteasome.
Sihn CR; Cho SY; Lee JH; Lee TR; Kim SH
Biochem Biophys Res Commun; 2007 Apr; 356(1):175-80. PubMed ID: 17349974
[TBL] [Abstract][Full Text] [Related]
19. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
[TBL] [Abstract][Full Text] [Related]
20. Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells.
Wang HQ; Du ZX; Zhang HY; Gao DX
Endocrinology; 2007 Jul; 148(7):3258-70. PubMed ID: 17431003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
